GlobalData on MSN2 个月
Boston Scientific expands FDA label for Ingevity+ pacing leads
The US Food and Drug Administration (FDA) has approved a label expansion for Boston Scientific’s current-generation Ingevity+ ...
Medscape29 天
Medium-term Effects of Septal and Apical Pacing in Pacemaker-Dependent Patients
Of both groups, 12 had a femoral temporary pacing lead placed during the procedure (seven in Group A and five in Group S). For this reason, only 27 in Group A had a spontaneous R wave with a ...